PRT for Chronic Low Back Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity Health Network, Toronto

About this trial

The goal of this clinical trial is to learn whether Pain Reprocessing Therapy (PRT) is a feasible and acceptable treatment to complete for working-age adults (ages 18-65) with chronic low back pain. The main questions it aims to answer are:

Is PRT acceptable and feasible for people with chronic low back pain to complete? Does PRT help reduce pain intensity and interference, while improving functional outcomes in people with chronic low back pain?

Researchers will compare PRT to a Monitoring and Education Program to see whether participants who receive PRT experience greater improvements in pain, daily functioning, and well-being.

Participants will:

* Be randomly assigned to the PRT group or the Monitoring and Education group * Participate in 8 intervention sessions over an 8-week period * Wear an activity monitor for 8 weeks * Attend a follow-up assessment after completing the intervention and another assessment 3 months later

Please note that ClinicalTrials.gov will be used solely as a public study registry and not as a participant recruitment tool. The study team will not recruit participants or accept self-referrals through ClinicalTrials.gov. All participant recruitment will occur only through the Research Ethics Board (REB) approved recruitment methods.

Eligibility criteria

Qualifiers

Working age adults (18-65)

Male or Female at birth

Persisting back pain for at least 3 months occurring at least half of the days in the past 6 months

Pain score of at least 4/10 (on a 10-point rating scale)

Disqualifiers

Compensation seeking claim/litigation/WSIB claim

Severe active psychiatric disorders (e.g., psychosis, substance use disorder)

An active medical issue such as untreated inflammatory disorder (e.g. ankylosing spondylitis, psoriatic arthritis)

Active cancers affecting the spine or body

Trial design

Treatments tested in this trial

  • Pain Reprocessing Therapy
  • Monitoring and Education

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University Health Network, Toronto

Lead sponsor

Workplace Safety and Insurance Board

Collaborator